MedTrace Logo

Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis

NCT01561248 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2012-03-22

No results posted yet for this study

Summary

The investigators examined the outcome of patients with severe Enterohaemorrhagic E. Coli (EHEC) O104:H4 infection suffering from bloody diarrhoea that were at risk to develop hemolytic uremic syndrome and underwent repetitive whole bowl lavage during hospitalization.

Conditions

  • Hemolytic Uremic Syndrome
  • Hemorrhagic Colitis
  • Intestinal Infectious Disease
  • Intestinal Infection Due to E. Coli

Interventions

DRUG

polyethylene glycol solution for daily bowel lavage.

At admission,patients with severe EHEC infection received two liters of orally administered electrolytes- balanced polyethylene glycol solution for bowel lavage. Treatment was continued with one liter of polyethylene glycol solution daily for repetitive intestinal lavage during the clinical course.

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Stefan Lüth, M.D. · Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg

  • Thorben Fründt, M.D. · Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-06-30
Completion
2012-02-29

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01561248 on ClinicalTrials.gov